A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation

Nucleic Acids Research

Volumn 43, Issue 8, 2015, Pages 4075-4086

  Hatano, Koji ^a   Kumar, Binod ^a   Zhang, Yonggang ^a   Coulter, Jonathan B ^a   Hedayati, Mohammad ^a   Mears, Brian ^a   Ni, Xiaohua ^a,b   Kudrolli, Tarana A ^a   Chowdhury, Wasim H ^a,c   Rodriguez, Ronald ^a,c   DeWeese, Theodore L ^a,d   Lupold, Shawn E ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 744 3P; MICRORNA 890; MICRORNA 890 MIMETIC; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA REPAIR; GENE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IONIZING RADIATION; MAD2L2 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROSTATE TUMOR; RADIOSENSITIVITY; RADIOSENSITIZATION; SINGLE DRUG DOSE; WEE1 GENE; XPC GENE; ANIMAL; GENETICS; MALE; METABOLISM; NUDE MOUSE; PATHOLOGY; PROSTATIC NEOPLASMS; RADIATION DOSE; TUMOR CELL LINE;

METRIDIA LUCIFERASE;

ANIMALS; CELL LINE, TUMOR; DNA REPAIR; HUMANS; MALE; MICE, NUDE; MICRORNAS; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; RADIATION, IONIZING;

EID: 84930226668     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv273     Document Type: Article

References (47)

1. Moding, E.J., Kastan, M.B. and Kirsch, D.G. (2013) Strategies for optimizing the response of cancer and normal tissues to radiation. Nat. Rev. Drug Discov., 12, 526-542.
2. Ni, X., Zhang, Y., Ribas, J., Chowdhury, W.H., Castanares, M., Zhang, Z., Laiho, M., DeWeese, T.L. and Lupold, S.E. (2011) Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts. J. Clin. Invest., 121, 2383-2390.
3. Lupold, S.E., Johnson, T., Chowdhury, W.H. and Rodriguez, R. (2012) A real time Metridia luciferase based non-invasive reporter assay of mammalian cell viability and cytotoxicity via the beta-actin promoter and enhancer. PLoS One, 7, e36535.
4. van Kouwenhove, M., Kedde, M. and Agami, R. (2011) MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat. Rev. Cancer, 11, 644-656.
5. Friedman, R.C., Farh, K.K., Burge, C.B. and Bartel, D.P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 19, 92-105.
6. Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
7. Calin, G.A. and Croce, C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
8. Kent, O.A. and Mendell, J.T. (2006) A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene, 25, 6188-6196.
9. Zhao, L., Bode, A.M., Cao, Y. and Dong, Z. (2012) Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis, 33, 2220-2227.
10. Czochor, J.R. and Glazer, P.M. (2014) microRNAs in cancer cell response to ionizing radiation. Antioxid. Redox Signal., 21, 293-312.
11. Cheung, H.W., Chun, A.C., Wang, Q., Deng, W., Hu, L., Guan, X.Y., Nicholls, J.M., Ling, M.T., Chuan Wong, Y., Tsao, S.W. et al. (2006) Inactivation of human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to DNA-damaging agents. Cancer Res., 66, 4357-4367.
12. Dyer, B.W., Ferrer, F.A., Klinedinst, D.K. and Rodriguez, R. (2000) A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal. Biochem., 282, 158-161.
13. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
14. Firsanov, D.V., Solovjeva, L.V. and Svetlova, M.P. (2011) H2AX phosphorylation at the sites of DNA double-strand breaks in cultivated mammalian cells and tissues. Clin. Epigenetics, 2, 283-297.
15. Betel, D., Koppal, A., Agius, P., Sander, C. and Leslie, C. (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol., 11, R90.
16. Weidhaas, J.B., Babar, I., Nallur, S.M., Trang, P., Roush, S., Boehm, M., Gillespie, E. and Slack, F.J. (2007) MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res., 67, 11111-11116.
17. Josson, S., Sung, S.Y., Lao, K., Chung, L.W. and Johnstone, P.A. (2008) Radiation modulation of microRNA in prostate cancer cell lines. Prostate, 68, 1599-1606.
18. Chen, G., Zhu, W., Shi, D., Lv, L., Zhang, C., Liu, P. and Hu, W. (2010) MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol. Rep., 23, 997-1003.
19. Wagner-Ecker, M., Schwager, C., Wirkner, U., Abdollahi, A. and Huber, P.E. (2010) MicroRNA expression after ionizing radiation in human endothelial cells. Radiat. Oncol., 5, 25.
20. Wang, X.C., Du, L.Q., Tian, L.L., Wu, H.L., Jiang, X.Y., Zhang, H., Li, D.G., Wang, Y.Y., Wu, H.Y., She, Y. et al. (2011) Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer, 72, 92-99.
21. Li, B., Shi, X.B., Nori, D., Chao, C.K., Chen, A.M., Valicenti, R. and White Rde, V. (2011) Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate, 71, 567-574.
22. Qu, C., Liang, Z., Huang, J., Zhao, R., Su, C., Wang, S., Wang, X., Zhang, R., Lee, M.H. and Yang, H. (2012) MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle, 11, 785-796.
23. Mueller, A.C., Sun, D. and Dutta, A. (2013) The miR-99 family regulates the DNA damage response through its target SNF2H. Oncogene, 32, 1164-1172.
24. He, L., He, X., Lim, L.P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D. et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134.
25. Chang, T.C., Wentzel, E.A., Kent, O.A., Ramachandran, K., Mullendore, M., Lee, K.H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C.J. et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell, 26, 745-752.
26. Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., Desano, J.T., Bommer, G.T., Fan, D. et al. (2009) MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One, 4, e6816.
27. Hu, H., Du, L., Nagabayashi, G., Seeger, R.C. and Gatti, R.A. (2010) ATM is down-regulated by N-Myc-regulated microRNA-421. Proc. Natl. Acad. Sci. U.S.A., 107, 1506-1511.
28. Yan, D., Ng, W.L., Zhang, X., Wang, P., Zhang, Z., Mo, Y.Y., Mao, H., Hao, C., Olson, J.J., Curran, W.J. et al. (2010) Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One, 5, e11397.
29. Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A., 103, 2257-2261.
30. Gwak, H.S., Kim, T.H., Jo, G.H., Kim, Y.J., Kwak, H.J., Kim, J.H., Yin, J., Yoo, H., Lee, S.H. and Park, J.B. (2012) Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One, 7, e47449.
31. Hudson, R.S., Yi, M., Esposito, D., Glynn, S.A., Starks, A.M., Yang, Y., Schetter, A.J., Watkins, S.K., Hurwitz, A.A., Dorsey, T.H. et al. (2013) MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer. Oncogene, 32, 4139-4147.
32. Gasparini, P., Lovat, F., Fassan, M., Casadei, L., Cascione, L., Jacob, N.K., Carasi, S., Palmieri, D., Costinean, S., Shapiro, C.L. et al. (2014) Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc. Natl. Acad. Sci. U.S.A., 111, 4536-4541.
33. Mirzayans, R., Andrais, B., Scott, A., Wang, Y.W. and Murray, D. (2013) Ionizing radiation-induced responses in human cells with differing TP53 status. Int. J. Mol. Sci., 14, 22409-22435.
34. Simone, C.B. 2nd, John-Aryankalayil, M., Palayoor, S.T., Makinde, A.Y., Cerna, D., Falduto, M.T., Magnuson, S.R. and Coleman, C.N. (2013) mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status. Transl. Oncol., 6, 573-585.
35. Harris, C.C. (1996) Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst., 88, 1442-1455.
36. Zhao, J., Liu, S., Wang, H., Zhang, X., Kang, T., Li, Z., Deng, H., Yue, W. and Cao, S. (2011) Mitotic arrest deficient protein MAD2B is overexpressed in human glioma, with depletion enhancing sensitivity to ionizing radiation. J. Clin. Neurosci., 18, 827-833.
37. Mueller, S., Hashizume, R., Yang, X., Kolkowitz, I., Olow, A.K., Phillips, J., Smirnov, I., Tom, M.W., Prados, M.D., James, C.D. et al. (2014) Targeting Wee1 for the treatment of pediatric high-grade gliomas. Neuro-oncol., 16, 352-360.
38. Bridges, K.A., Hirai, H., Buser, C.A., Brooks, C., Liu, H., Buchholz, T.A., Molkentine, J.M., Mason, K.A. and Meyn, R.E. (2011) MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Clin. Cancer Res., 17, 5638-5648.
39. Chavanne, F., Broughton, B.C., Pietra, D., Nardo, T., Browitt, A., Lehmann, A.R. and Stefanini, M. (2000) Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res., 60, 1974-1982.
40. Despras, E., Pfeiffer, P., Salles, B., Calsou, P., Kuhfittig-Kulle, S., Angulo, J.F. and Biard, D.S. (2007) Long-term XPC silencing reduces DNA double-strand break repair. Cancer Res., 67, 2526-2534.
41. Liang, F., Romanienko, P.J., Weaver, D.T., Jeggo, P.A. and Jasin, M. (1996) Chromosomal double-strand break repair in Ku80-deficient cells. Proc. Natl. Acad. Sci. U.S.A., 93, 8929-8933.
42. Petrocca, F., Visone, R., Onelli, M.R., Shah, M.H., Nicoloso, M.S., de Martino, I., Iliopoulos, D., Pilozzi, E., Liu, C.G., Negrini, M. et al. (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell, 13, 272-286.
43. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A.O., Landthaler, M. et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401-1414.
44. Belleannee, C., Calvo, E., Thimon, V., Cyr, D.G., Legare, C., Garneau, L. and Sullivan, R. (2012) Role of microRNAs in controlling gene expression in different segments of the human epididymis. PLoS One, 7, e34996.
45. Yeung, C.H., Wang, K. and Cooper, T.G. (2012) Why are epididymal tumours so rare? Asian J. Androl., 14, 465-475.
46. Janssen, H.L., Reesink, H.W., Lawitz, E.J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A.J., Patick, A.K., Chen, A., Zhou, Y. et al. (2013) Treatment of HCV infection by targeting microRNA. N. Engl. J. Med., 368, 1685-1694.
47. Ling, H., Fabbri, M. and Calin, G.A. (2013) MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug. Discov., 12, 847-865.